All Cancers

IRB #H-38024/ BMC #Biobank: Prospective Collection of Microbiome and Associated Biologic Samples in Patients with Malignancies and Hematologic Diseases

Metastatic/Advanced 2nd+ Line Solid Tumors:

KRAS/NRAS/HRAS/BRAF positive
CIRB #H-42956/ ETCTN #10449: A Phase 1 Study of ZEN003694 in Combination with Binimetinib in Solid Tumors with RAS Pathway Alterations and Triple Negative Breast Cancer (temporary closure)